Status:
UNKNOWN
Outcomes of Patients With Venoarterial Extracorporeal Membrane Oxygenation
Lead Sponsor:
Beijing Anzhen Hospital
Conditions:
Cardiogenic Shock
Cardiac Arrest
Eligibility:
All Genders
Brief Summary
Venoarterial extracorporeal membrane oxygenation (VA ECMO)-also referred to as extracorporeal life support-is a form of temporary mechanical circulatory support and simultaneous extracorporeal gas exc...
Eligibility Criteria
Inclusion
- Patients receiving VA ECMO for cardiopulmonary support
Exclusion
- Refusal of consent
Key Trial Info
Start Date :
August 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 31 2025
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04039594
Start Date
August 1 2019
End Date
July 31 2025
Last Update
August 6 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Center for Cardiac Intensive Care, Beijing Anzhen Hospital, Capital Medical University
Beijing, Beijing Municipality, China, 100029